PTC Therapeutics Inc
PTCT
Company Profile
Business description
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Contact
100 Corporate Court
South PlainfieldNJ07080
USAT: +1 908 222-7000
E: akane@ptcbio.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
995
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,416.60 | 57.70 | -0.68% |
CAC 40 | 7,541.36 | 63.58 | 0.85% |
DAX 40 | 19,120.93 | 105.52 | 0.55% |
Dow JONES (US) | 42,352.75 | 341.16 | 0.81% |
FTSE 100 | 8,280.63 | 1.89 | -0.02% |
HKSE | 22,736.87 | 623.36 | 2.82% |
NASDAQ | 18,137.85 | 219.37 | 1.22% |
Nikkei 225 | 38,635.62 | 83.56 | 0.22% |
NZX 50 Index | 12,619.94 | 47.28 | 0.38% |
S&P 500 | 5,751.07 | 51.13 | 0.90% |
S&P/ASX 200 | 8,150.00 | 55.20 | -0.67% |
SSE Composite Index | 3,336.50 | 248.97 | 8.06% |